Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 07, 2024

SELL
$65.94 - $99.04 $127,659 - $191,741
-1,936 Reduced 3.2%
58,620 $4 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $127,659 - $191,741
-1,936 Reduced 3.2%
58,620 $4 Million
Q2 2023

Oct 07, 2024

BUY
$62.68 - $95.05 $3.8 Million - $5.76 Million
60,556 New
60,556 $5.69 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $3.8 Million - $5.76 Million
60,556 New
60,556 $5.69 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $39.4 Million - $53.4 Million
-435,728 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $1.27 Million - $1.67 Million
14,188 Added 3.37%
435,728 $51.4 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $26.1 Million - $40.7 Million
421,540 New
421,540 $36.5 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $56.7 Million - $94.6 Million
-1,173,304 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $33.6 Million - $62.2 Million
888,841 Added 312.46%
1,173,304 $70.2 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $12.7 Million - $18.3 Million
-317,843 Reduced 52.77%
284,463 $11.5 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $42 Million - $54.7 Million
-903,317 Reduced 60.0%
602,306 $31.6 Million
Q3 2017

Nov 14, 2017

SELL
$37.05 - $47.12 $31.5 Million - $40.1 Million
-851,083 Reduced 36.11%
1,505,623 $70.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,356,706
2,356,706 $83.4 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.